CClinicalTrials.gg
CompletedNCT05622747Updated Aug 6, 2025

Acute Passive Heating in Healthy Older Adults

An interventional study of Passive heating in Aging, sponsored by University of Portsmouth. Completed at 1 site in United Kingdom. Open to participants aged 55 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-06.

Sponsored by University of Portsmouth · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
23
Allocation
Not applicable
Ages
55 Years and older
Sex
All
01

Study summary

Aging is associated with a decline in cardiovascular health, cognitive function and losses in muscle strength, with half or more of those over age 65 suffering from two or more comorbidities (e.g., heart disease, type 2 diabetes). The worldwide population of older adults is growing rapidly, with one in six people expected to be over age 65 by 2050. This will place further financial burden from chronic diseases on already stressed healthcare systems. While studies show that frequent exercise is an effective way for older adults to maintain or improve cardiovascular and metabolic health, older individuals are less physically active and do not adhere well to exercise programs, often due to physical or medical limitations. Therefore, alternative methods for older adults to get the same health benefits as exercise require further exploration. Recent work has shown a single session of passive heat therapy could be an alternative way to improve cardiovascular health and cognitive function in various populations, however, the length of time that these benefits last is yet to be explored.

Read the detailed description

Aging is associated with declines in cardiovascular health and cognitive function as well as chronic inflammation and the development of neurodegenerative conditions such as Alzheimer's and Parkinson's disease. Additionally, ageing results in a loss of muscle size and strength, commonly referred to as sarcopenia, leading to increased risk of falls or adverse exercise-related events. It is well understood that frequent exercise improves cardiovascular and metabolic health whilst lowering the risk of disease and all-cause mortality, acting as a treatment for many different health conditions. Despite the evidence of its efficacy, many individuals struggle with adherence to exercise programmes, particularly older adults and clinical populations, with many individuals within these populations unable to perform exercise due to physical limitations or medical contraindications. With one in six people expected to be over the age of 65 years by 2050 and corresponding increases in non-communicable diseases (e.g., cancer, diabetes, cardiovascular disease) anticipated from this aging population, the development of adjunct treatments or alternatives to exercise to improve general health in older populations is needed.

Recent work has shown one such potential solution could be the use of passive heat therapy (PHT) (e.g., hot water immersion, sauna), which can achieve health benefits comparable to exercise. Acute PHT induces vascular improvements including increased blood flow, reduced blood pressure. and macro- and microvascular dilator function in various populations. Acute PHT has also been shown to increase reaction time, while mixed results have been seen in its effect on executive function in both young and older populations. The mechanisms for these improvements, however, are currently unclear, and may be related to increases in nitric oxide activity or reductions in biomarkers of inflammation.

One potential mechanism for the physiological benefits obtained from PHT is the increase of cytoprotective heat shock proteins (HSP) (specifically HSP27, HSP60, HSP70 and HSP90) intracellularly (i) and extracellularly (e) in response to increases in deep body temperature. Increases in the expression of these HSPs have been shown to play a role in reducing inflammation and protecting the vasculature via increases in endothelial nitric oxide synthase activity. Increased HSP concentrations may also prevent the accumulation of harmful biomarkers in the brain that play a role in cognitive decline and development of neurodegenerative diseases. There is also evidence that increased preoperative levels of both iHSP70 and eHSP70 are correlated with improved postoperative outcomes following cardiac surgery. Aging, however, is associated with a reduction in HSP transcription activity in various tissues, resulting in an impaired heat shock response and development of a pro-inflammatory state.

Previous work using acute hot water immersion has shown mixed results, with various studies showing increases in eHSP70, iHSP70 and iHSP90, while others have reported no change in expression. Heating stimuli applied in these studies has varied in magnitude, duration and whole body or not, and measurements of HSPs have taken place at various time points before, during and after PHT. Therefore, it is possible that upregulation of HSPs may have been missed, as no time course relationship exists between a single bout of PHT and upregulation of HSPs. Additionally, the duration for acute vascular and cognitive benefits from PHT and when function is returned to baseline is yet to be determined. A time course relationship study to determine the peak HSP response to acute passive heat therapy in older adults would provide insight into the relationship between acute changes in vascular or cognitive function and concurrent upregulation of both intracellular and extracellular HSPs, as well as its potential implications for improved surgical outcomes.

02

Conditions studied

  • Aging

Keywords

  • Passive heating
  • Endothelial function
  • Heat shock proteins
  • Cognitive function
03

In context

Lead sponsor

University of Portsmouth is the lead sponsor of 32 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Male or female age ≥ 55
  • Free from cardiometabolic disease
  • Body mass index of 18-35 kg/m2
  • Receipt of a normal 12-lead ECG approved by the School Independent Medical Officer
  • Capacity to understand and provide their written, informed consent to participate in the study protocol

Exclusion criteria

Exclusion Criteria:

  • Unable to understand or cooperate with the study protocol due to learning difficulties or otherwise
  • Any current, or past medical (last five years), history of any cardiovascular, respiratory, cancer, renal, hepatic, gastrointestinal, haematological, lymphatic, neurological, psychiatric, or any other disease or diseases.
  • Any regular medication for the last five years (not including acute courses of treatment of less than one month for discrete, resolved conditions).
  • Medications that may influence physiological responses to the passive heating intervention Uncontrolled hypertension (≥ 150 mmHg systolic and/or ≥ 90 mmHg diastolic)
  • Body mass index of > 35 kg/m2
  • Recent long-term exposure to a hot climate (within the previous three months)
  • Current smoker (or have stopped smoking within the previous three months)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
23 participants (actual)

Study arms

  • Experimental
    Passive heating intervention

    1 h hot water immersion (to the clavicle, @40°C, rectal temperature \~38.5°C and \<39°C)

    Other: Passive heating

Interventions

  • OtherPassive heating

    1 h hot water immersion (to the clavicle, @40°C, rectal temperature \~38.5°C and \<39°C)

06

What researchers measure

Primary outcomes

  1. Brachial artery flow-mediated dilation

    Percentage change in brachial artery diameter and return to baseline as assessed by ultrasound.

    Time frame: Pre hot water immersion, then 1 hour, 3 hours, 24 hours and 48 hours post

Secondary outcomes

  1. Brachial and carotid artery blood flow velocity

    Change from baseline in blood flow velocity of the brachial artery and right common carotid artery as assessed via ultrasound. cm/s is the unit.

    Time frame: Pre hot water immersion, then 1 hour, 3 hours, 24 hours and 48 hours post

  2. Carotid vessel diameter

    Change in vessel diameter of the right common carotid artery and return to baseline as assessed via ultrasound. mm is the unit.

    Time frame: Pre hot water immersion, then 1 hour, 3 hours, 24 hours and 48 hours post

  3. Carotid intima-media thickness

    Change in intima-media thickness of the right common carotid artery and return to baseline as assessed via ultrasound. mm is the unit.

    Time frame: Pre hot water immersion, then 1 hour, 3 hours, 24 hours and 48 hours post

  4. Carotid compliance

    Change in compliance of the right common carotid artery and return to baseline as assessed via ultrasound. µm\^2 per kilopascal is the unit.

    Time frame: Pre hot water immersion, then 1 hour, 3 hours, 24 hours and 48 hours post

  5. Carotid distensibility

    Change in distensibility of the right common carotid artery and return to baseline as assessed via ultrasound. 10\^-3/kPa is the unit.

    Time frame: Pre hot water immersion, then 1 hour, 3 hours, 24 hours and 48 hours post

  6. Carotid stiffness

    Change in stiffness of the right common carotid artery and return to baseline as assessed via ultrasound. Meters per second is the unit.

    Time frame: Pre hot water immersion, then 1 hour, 3 hours, 24 hours and 48 hours post

  7. Microvascular function

    Change in microvascular function and return to baseline as assessed via iontophoresis on the forearm with acetylcholine (Ach) and Insulin, Area under the curve is the unit.

    Time frame: Pre hot water immersion, then 1 hour, 3 hours, 24 hours and 48 hours post

  8. Stroke volume

    Change in stroke volume and return to baseline measured noninvasively via thoracic impedance. mL/m\^2 is the unit

    Time frame: Pre hot water immersion, then 1 hour, 3 hours, 24 hours and 48 hours post

  9. Total peripheral resistance

    Change in total peripheral resistance and return to baseline measured noninvasively via thoracic impedance

    Time frame: Pre hot water immersion, then 1 hour, 3 hours, 24 hours and 48 hours post

  10. Cardiac output

    Change in cardiac output and return to baseline measured noninvasively via thoracic impedance. L/min is the unit.

    Time frame: Pre hot water immersion, then 1 hour, 3 hours, 24 hours and 48 hours post

  11. Intracellular HSP27 concentration

    Change in iHSP27 concentration and return to baseline. Measured via immunoblotting in peripheral blood mononuclear cells (PBMCs).

    Time frame: Pre hot water immersion, then immediately post, 1 hour, 2 hours, 3 hours, 6 hours, 12 hours, 24 hours and 48 hours post

  12. Intracellular HSP60 concentration

    Change in iHSP60 concentration and return to baseline. Measured via immunoblotting in peripheral blood mononuclear cells (PBMCs).

    Time frame: Pre hot water immersion, then immediately post, 1 hour, 2 hours, 3 hours, 6 hours, 12 hours, 24 hours and 48 hours post

  13. Intracellular HSP70 concentration

    Change in iHSP70 concentration and return to baseline. Measured via immunoblotting in peripheral blood mononuclear cells (PBMCs).

    Time frame: Pre hot water immersion, then immediately post, 1 hour, 2 hours, 3 hours, 6 hours, 12 hours, 24 hours and 48 hours post

  14. Intracellular HSP90 concentration

    Change in iHSP90 concentration and return to baseline. Measured via immunoblotting in peripheral blood mononuclear cells (PBMCs).

    Time frame: Pre hot water immersion, then immediately post, 1 hour, 2 hours, 3 hours, 6 hours, 12 hours, 24 hours and 48 hours post

  15. Plasma eHSP27 concentration

    Change in plasma eHSP27 concentration and return to baseline. Measured via ELISA.

    Time frame: Pre hot water immersion, then immediately post, 1 hour, 2 hours, 3 hours, 6 hours, 12 hours, 24 hours and 48 hours post

  16. Plasma eHSP60 concentration

    Change in plasma eHSP60 concentration and return to baseline. Measured via ELISA.

    Time frame: Pre hot water immersion, then immediately post, 1 hour, 2 hours, 3 hours, 6 hours, 12 hours, 24 hours and 48 hours post

  17. Plasma eHSP70 concentration

    Change in plasma eHSP70 concentration and return to baseline. Measured via ELISA.

    Time frame: Pre hot water immersion, then immediately post, 1 hour, 2 hours, 3 hours, 6 hours, 12 hours, 24 hours and 48 hours post

  18. Plasma eHSP90 concentration

    Change in plasma eHSP90 concentration and return to baseline. Measured via ELISA.

    Time frame: Pre hot water immersion, then immediately post, 1 hour, 2 hours, 3 hours, 6 hours, 12 hours, 24 hours and 48 hours post

  19. Reaction time

    Change in reaction time and return to baseline as assessed using ANAM: Automated Neurophysiological Assessment Metrics.

    Time frame: Pre hot water immersion, then immediately post, 3 hours, 24 hours and 48 hours post

  20. Logical reasoning

    Change in logical reasoning and return to baseline as assessed using ANAM: Automated Neurophysiological Assessment Metrics.

    Time frame: Pre hot water immersion, then immediately post, 3 hours, 24 hours and 48 hours post

  21. Memory

    Change in memory function and return to baseline as assessed using ANAM: Automated Neurophysiological Assessment Metrics.

    Time frame: Pre hot water immersion, then immediately post, 3 hours, 24 hours and 48 hours post

  22. Cerebral oxygenation

    Change in cerebral oxygenation and return to baseline. Assessed using Near-infrared spectroscopy (NIRS) attached to the forehead

    Time frame: Pre hot water immersion, then immediately post, 3 hours, 24 hours and 48 hours post

07

Study locations

1 site
  • Spinnaker Building
    Portsmouth, Hampshire PO4 0SU, United Kingdom
08

References and documents

Individual participant data

Plan to share: Yes — All data will be anonymized and raw data uploaded to the University of Portsmouth repository.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05622747
Lead sponsor
University of Portsmouth
Responsible party
Ant Shepherd (Senior Lecturer in Physical Activity, Exercise and Health, University of Portsmouth) — Principal investigator
First posted
Nov 21, 2022
Start date
May 23, 2023
Primary completion
Jul 24, 2025
Completion
Jul 24, 2025
Last update
Aug 6, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion